From May 11, 2023 to June 9, 2023, the company has repurchased 8,085,879 shares, representing 48.15% for $26.46 million. With this, the company has completed the repurchase of 8,085,879 shares, representing 48.15% for $26.46 million under the buyback announced on May 11, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | +3.77% | +3.29% | +1.85% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.85% | 17.92M | |
+34.74% | 664B | |
+29.35% | 567B | |
-7.12% | 354B | |
+19.53% | 330B | |
+4.44% | 286B | |
+13.55% | 234B | |
+5.35% | 199B | |
-9.94% | 196B | |
-4.66% | 148B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on May 11, 2023.